Efficacy and safety of low‐dose antihypertensive combination of amlodipine, telmisartan, and chlorthalidone: A randomized, double‐blind, parallel, phase II trial

Abstract The aim of this clinical trial was to assess the efficacy and safety of low‐dose triple combinations of amlodipine, telmisartan, and chlorthalidone in patients with essential hypertension. After a 2‐week placebo run‐in period, 176 patients were randomized to seven treatment groups (placebo,...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Ki‐Chul Sung, Jung Hoon Sung, Eun Joo Cho, Jeong Cheon Ahn, Seung Hwan Han, Weon Kim, Kye Hun Kim, Il Suk Sohn, Jinho Shin, Seok Yeon Kim, Kwang‐il Kim, Seok Min Kang, Sung‐Ji Park, Yong‐Jin Kim, Joon‐Han Shin, Seong‐Mi Park, Chang‐Gyu Park
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2022-10-01
Serie:	The Journal of Clinical Hypertension
Soggetti:	amlodipine chlorthalidone hypertension low‐dose combination telmisartan
Accesso online:	https://doi.org/10.1111/jch.14570
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!